Boston Heart Diagnostics provides information on cardiovascular health for the prevention and management of heart issues, diabetes, and hormonal and nutritional disorders, aiming for a patient-focused, comprehensive approach to better support care.
As a laboratory dedicated to the detection and management of heart disease, Boston Heart Diagnostics leverages innovative testing solutions to provide precise, actionable insights into cardiovascular health.
Founded in 2007 and headquartered in Framingham, Massachusetts, Boston Heart Diagnostics is “transforming the treatment of cardiovascular disease and related diseases with novel diagnostics, reports, and a personalized, scientifically designed nutrition and lifestyle program that have the power to change the way healthcare providers and patients communicate about heart health.”
Boston Heart Diagnostics ensures quality diagnostic testing through certification and enacted policies and procedures. Their medical and scientific teams support both patients and physicians with educational materials and the development of nutrition and lifestyle programs.
Boston Heart Diagnostics’ Scientific Advisory Board is composed of recognized experts in their respective medical fields, including lipoprotein testing, insulin resistance, diabetes, obesity, nutrition, lifestyle, and conditions related to cardiovascular health.
Boston Heart Diagnostics’ Leadership Team is dedicated to accomplishing its mission of enabling everyone to improve health and prevent disease.
They specialize in various laboratory techniques, including gas chromatography, gel electrophoresis, genetic testing, general chemistry, immunoassay, and high-performance liquid chromatography.
Highly qualified laboratory staff operate state-of-the-art equipment to ensure accurate and consistent assay performance.
Boston Heart Diagnostics is transforming the treatment of cardiovascular disease and related diseases with novel diagnostics, reports, and a personalized, scientifically designed nutrition and lifestyle program that have the power to change the way healthcare providers and patients communicate about heart health.
Their approach involves a three-phase process that is integral to their success:
Characterize:
Boston Heart utilizes novel diagnostics to produce reports with color-coded test results, interpretations, and clinical treatment considerations. This enhances understanding of risk, fosters deeper insights, and improves patient communication and engagement.
Individualize:
The diagnostic reports from Boston Heart transform test results into actionable, personalized, and easy-to-understand steps. This approach boosts patient engagement, health literacy, and adherence to treatment plans.
Engage:
Boston Heart’s Personalized Nutrition and Life Plan leverages lab results and individual food preferences to offer tailored lifestyle recommendations. This helps patients improve their test outcomes and lower their risk of chronic diseases.
Boston Heart Diagnostics is committed to delivering high-quality diagnostic tests with a focus on cardiovascular health.
Boston Heart Diagnostics upholds rigorous quality assurance protocols to ensure the accuracy and reliability of every test performed.
They state that “[A]t Boston Heart, we view compliance and quality as one of the most essential parts of our business. We are committed to quality and have implemented policies, processes, and procedures to ensure that quality standards are achieved and exceeded.”
Boston Heart Diagnostics has obtained numerous certifications and accreditations from recognized healthcare and laboratory oversight bodies.
Boston Heart Diagnostics is both CLIA-Certified and CAP-Accredited.
Additionally, they hold Clinical Laboratory Permits and/or Licenses in multiple states.
Boston Heart Diagnostics specializes in a wide array of diagnostic tests primarily focused on cardiometabolic health. They offer many routine blood work assessments including complete blood count with differential, a basic lipid panel, high-sensitivity C-reactive protein (hsCRP), a thyroid panel, and more.
Their array of exclusive test panels are designed to provide additional, actionable insight into an individual’s cardiovascular risk.
Many tests are available as blood and/or blood spot tests; some tests utilize saliva samples.
Boston Heart Diagnostics has designed exclusive test panels to assess various aspects of cardiometabolic risk.
CVMap:
Boston Heart Diagnostics' CVMap offers a comprehensive evaluation of cardiovascular disease (CVD) risk by enhancing traditional lipid assessments with a unique combination of biomarkers such as lipid and Lp(a) levels, lipid particle numbers, inflammation markers, and Boston Heart’s exclusive Cholesterol Balance.
GI Balance:
By offering a detailed analysis of the gut microbiome, this test integrates cardiovascular and gastrointestinal health. The report delivers insights into the microbiome's condition and identifies specific nutrients required to optimize gut health on an individual basis.
Polygenic Risk Map: Male Complete:
Boston Heart’s Polygenic Risk Map test is a genetic test that leverages Polygenic Risk Score (PRS) analysis and reporting to provide clinical insights into a variety of important health conditions.
Polygenic Risk Map: Female Complete:
Boston Heart’s Polygenic Risk Map test is a genetic test that leverages Polygenic Risk Score (PRS) analysis and reporting to provide clinical insights into a variety of important health conditions.
The LipoMap® test is a panel of 33 lipid and lipoprotein tests to provide the most complete assessment of lipid metabolism commercially available for use in clinical practice.
Essential Fatty Acids Test and the Boston Heart Fatty Acid Balance Test:
Fatty acids play a crucial role in heart health. Properly balancing fatty acids can enhance cholesterol and triglyceride profiles, boost immune function, and decrease inflammation and heart disease risk.
The Essential Fatty Acids test measures all the major fatty acids in plasma and reports:
The Boston Heart Fatty Acid Balance™ test measures all the major fatty acids in plasma and reports:
Beta Cell Function and Risk Index:
The Beta Cell Function and Risk Index is a calculation based on fasting glucose and insulin (or c-peptide) designed to give insights into beta cell function. It provides an assessment of baseline beta cell function to inform treatment options and follow changes over time.
Boston Heart Statin Induced Myopathy (SLCO1B1) Genotype Test:
The SLCO1B1 gene plays a key role in how the body absorbs and metabolizes statins, which are medications used to lower LDL-C levels to prevent heart attacks and strokes. The most common side effects of statin therapy are statin-associated muscle symptoms (SAMS), which include muscle aches, spasms, weakness, and pain.
Boston Heart Prediabetes Assessment Test:
The prevalence of diabetes and prediabetes in the U.S. is on the rise. This test attempts to provide early diagnosis to reduce risk of cardiometabolic-associated morbidity and mortality.
A method of predicting the risk of developing diabetes (fasting serum glucose > 125 mg/dL) in subjects with prediabetes (fasting serum glucose 100 – 125 mg/dL). This method uses information about the person’s height, weight, parental history of diabetes, and use of cholesterol lowering medications (statins and niacin) along with the following measurements: fasting glucose, glycated serum protein, adiponectin, and triglycerides. This method provides a highly accurate assessment of the 10 year diabetes risk (over 92% accurate).
The Boston Heart HDL Map® test measures the five most significant HDL subpopulations in CVD risk using a proprietary gel electrophoresis technique. This process quantifies the amount of apoA-I protein in each of the five HDL subclasses, providing information to accurately identify patients at increased CVD risk.
Boston Heart Cholesterol Balance Test:
Boston Heart Diagnostics Cholesterol Balance® test measures markers of cholesterol production (lathosterol and desmosterol) and absorption (beta-sitosterol, campesterol, and cholestanol). It is also offered with total cholesterol levels.
In addition to their exclusive panels listed above, Boston Heart Diagnostics offers individual tests to complement test panels.
Boston Heart Diagnostics provides several tests crucial for identifying prediabetes as well as identifying, managing and monitoring diabetes.
Boston Heart Diagnostics offers tests that are vital for diagnosing and monitoring thyroid disorders.
Tests such as Vitamin D, 25-OH and Vitamin B12 are crucial for assessing nutrient deficiencies that can have wide-ranging effects on health.
Boston Heart Diagnostics offers specialized panels like the Female Hormone Panel and the Male Hormone Panel, which assess key hormones affecting reproductive and overall health.
Boston Heart Diagnostics also offers a variety of tests and test panels to assess an individual’s genetic tendency toward cardiometabolic health vs. disease.
In addition to a wide range of general blood work panels and a variety of individual biomarkers, Boston Heart Diagnostics also offers the following exclusive panels:
CVMap
CVD and Diabetes Prevention Essentials
CVD and Diabetes Prevention Comprehensive
CardioMetabolic - Comprehensive
GI Balance
Polygenic Risk Map - Male Complete
Polygenic Risk Map - Female Complete
Essential Fatty Acids
Beta Cell Function and Risk Index
Boston Heart Fatty Acid Balance Test
Boston Heart Statin Induced Myopathy (SLCO1B1) Genotype Test
Boston Heart Prediabetes Assessment Test
Boston Heart HDL Map Test (Particles Only)
Boston Heart Cholesterol Balance Test
BostonHeart does basic bloodwork and cardio-metabolic labs in all-cash pricing, with no order minimum.
.svg){kind=small}
.svg){kind=small}
.jpg)
